Loncom Pharma's Cardiovascular APIS, including Levosimendan and Vericiguat, are instrumental in the development of cardiovascular medications. These APIs enhance cardiac function and vasodilation, offering hope to patients with heart conditions.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
